Skip to main content

Table 1 The aberrant expressions of BKCa, ERK1/2 and p-ERK1/2 in tissue samples of type I endometrial carcinoma, atypical endometrial hyperplasia and normal endometrium

From: BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway

Proteins

Expression level

Endometrial adenocarcinoma (n = 185)

Atypical endometrial hyperplasia (n = 38)

Normal endometrium (n = 40)

BKCa

High

68

2

2

Low

117

36

38

ERK1/2

High

110

5

2

Low

75

33

38

p-ERK1/2

High

93

12

1

Low

92

26

39